Ropes & Gray advised TPG in the sale of Immucor, Inc. to Werfen for approximately $2 billion, with closing subject to customary regulatory approvals. The announcement was made public on Nov. 3 in a press release.
TPG is a global alternative asset management firm with $127 billion of assets under management and investment and operational teams in 12 offices globally. Immucor, headquartered in Norcross, Georgia, has a global presence in transfusion and transplant in vitro diagnostics.
The Ropes & Gray team was led by private equity partners Michael Roh and James C. Davis, and included private equity partner Scott Rolnik, tax partner Adam Greenwood, benefits partner Matt Jones, litigation & enforcement partners Ruchit Patel and Annie Herdman, private equity counsel Walton Dumas and private equity associate Rebecca Yang.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.